As of 2025-07-06, the EV/EBITDA ratio of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC.IS) is 6.1. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SELEC.IS's latest enterprise value is 4,588 mil TRY. SELEC.IS's TTM EBITDA according to its financial statements is 757 mil TRY. Dividing these 2 quantities gives us the above SELEC.IS EV/EBITDA ratio.
Range | Selected | |
Trailing EV/EBITDA multiples | 6.2x - 9.2x | 7.7x |
Forward EV/EBITDA multiples | 9.7x - 12.1x | 10.9x |
Fair Price | 3.87 - 16.27 | 8.98 |
Upside | -65.6% - 44.8% | -20.1% |
(TRY in millions except Fair Price) | |||
Trailing | Forward | ||
Market Cap (TRY mil) | EV/EBITDA | EV/EBITDA | |
Selcuk Ecza Deposu Ticaret ve Sanayi AS | 5,383 | 6.1x | 42.3x |
Bastide le Confort Medical SA | 10,763 | 5.8x | 6.6x |
Galenica AG | 222,723 | 16.2x | 17x |
Haemato AG | NaN | 9.2x | 10.5x |
Medios AG | 15,162 | 6.2x | 11.2x |
Medcom Tech SA | 420 | 11x | 13.4x |
Neuca SA | 34,673 | 9.3x | 9.8x |
Uniphar PLC | 44,539 | 10x | 8.6x |
Amexdrug Corp | 14 | 1.2x | 2.6x |
Owens & Minor Inc | 28,129 | 5.1x | 22.4x |
Industry median | 7.7x | 10.9x | |
(*) EBITDA | 757 | 109 | |
Enterprise value | 5,831 | 1,177 | |
(-) Net debt | (795) | (795) | |
Equity value | 6,626 | 1,972 | |
(/) Outstanding shares | 479 | 479 | |
Fair price | 14 | 4 | |